The PE Ratio as of December 2025 (TTM) for BioNexus Gene Lab Corp. (BGLC) is -3.38

According to BioNexus Gene Lab Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -3.38. This represents a change of 22.75% compared to the average of -2.75 of the last 4 quarters.

BioNexus Gene Lab Corp. (BGLC) Historical PE Ratio (quarterly & annually)

How has BGLC PE Ratio performed in the past?

The mean historical PE Ratio of BioNexus Gene Lab Corp. over the last ten years is -21450.35. The current -3.38 PE Ratio has changed -98.42% with respect to the historical average. Over the past ten years (40 quarters), BGLC's PE Ratio was at its highest in in the March 2022 quarter at 4.29K. The PE Ratio was at its lowest in in the September 2019 quarter at -2005.29.

BioNexus Gene Lab Corp. (BGLC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BioNexus Gene Lab Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioNexus Gene Lab Corp. (BGLC) Average PE Ratio

How has BGLC PE Ratio performed in the past?

The current PE Ratio of BioNexus Gene Lab Corp. (BGLC) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

BioNexus Gene Lab Corp. (BGLC) PE Ratio vs. Peers

How is BGLC’s PE Ratio compared to its peers?

BioNexus Gene Lab Corp.’s PE Ratio is less than Advanced Biomed Inc. Common Stock (-3.36), less than Trinity Biotech plc (-0.49), less than Check-Cap Ltd. (-0.43), less than Aptorum Group Limited (-1.84), less than Beyond Air, Inc. (-0.15), greater than Mustang Bio, Inc. (-16.20), less than Galecto, Inc. (-1.92), greater than Lifeward Ltd. (-3.76), less than Lyra Therapeutics, Inc. (-0.16), greater than AEON Biopharma, Inc. (-2902.68),

Build a custom stock screener for BioNexus Gene Lab Corp. (BGLC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioNexus Gene Lab Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioNexus Gene Lab Corp. (BGLC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioNexus Gene Lab Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.